Loading clinical trials...

Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome | Clinical Trials | Clareo Health

UNKNOWNPhase 2NCT00004347

Phase II Study of Dietary Cholesterol for Smith-Lemli-Opitz Syndrome

OBJECTIVES: I. Examine the intestinal absorption of dietary cholesterol in patients with Smith-Lemli-Opitz syndrome. II. Measure the effect of dietary cholesterol on plasma sterol composition. III. Q...

Lead sponsor: National Center for Research Resources (NCRR)•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETED

Study of Smith-Lemli-Opitz Syndrome

NCT00001721 · Smith-Lemli-Opitz Syndrome

TERMINATEDNA

SLOS: The Effect of Simvastatin in Patients Receiving Cholesterol Supplementation

NCT01434745 · Smith-Lemli-Opitz Syndrome

TERMINATEDNA

Sterol and Isoprenoid Disease Research Consortium: Smith-Lemli-Opitz Syndrome

NCT01356420 · Smith-Lemli-Opitz Syndrome

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 24, 2005Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2

Enrollment5

Start dateNov 1995

Last updatedJun 24, 2005

Condition

Smith-Lemli-Opitz Syndrome

Locations shown

Oregon Health and Science University

Portland, Oregon

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 24, 2005Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions